NCT03593239View on ClinicalTrials.gov

Comparing the Pharmacokinetics of Nicotine Salt Based ENDS in Healthy Smokers

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 29, 2018

Primary Completion Date

July 26, 2018

Study Completion Date

July 26, 2018

Conditions
Nicotine DependenceNicotine Dependence, CigarettesTobacco UseTobacco Smoking
Interventions
OTHER

Tobacco flavored JUUL 1.7% ENDS

Treatment with Tobacco flavored JUUL 1.7% ENDS (10 puffs)

OTHER

Tobacco flavored JUUL 5% ENDS

Treatment with Tobacco flavored JUUL 5% ENDS(10 puffs)

OTHER

Mint flavored JUUL 1.7% ENDS

Treatment with Mint flavored JUUL 1.7% ENDS(10 puffs)

OTHER

Mint flavored JUUL 5% ENDS

Treatment with Mint flavored JUUL 5% ENDS(10 puffs)

OTHER

Fruit Medley flavored JUUL 1.7% ENDS

Treatment with Fruit Medley flavored JUUL 1.7% ENDS(10 puffs)

OTHER

Fruit Medley flavored JUUL 5% ENDS

Treatment with Fruit Medley flavored JUUL 5% ENDS(10 puffs)

OTHER

Crème brulee flavored JUUL 1.7% ENDS

Treatment with Crème brulee flavored JUUL 1.7% ENDS(10 puffs)

OTHER

Crème brulee flavored JUUL 5% ENDS

Treatment with Crème brulee flavored JUUL 5% ENDS(10 puffs)

OTHER

JUUL 1.7% ENDS 10 puffs vs. ad lib puffs

Treatment with JUUL 1.7% ENDS 10 puffs vs. ad libitum puffs

OTHER

JUUL 5% ENDS 10 puffs vs. ad lib puffs

Treatment with JUUL 5% ENDS 10 puffs vs. ad libitum puffs

Trial Locations (1)

8011

Christchurch Clinical Studies Trust Ltd, Christchurch

All Listed Sponsors
lead

Juul Labs, Inc.

INDUSTRY

NCT03593239 - Comparing the Pharmacokinetics of Nicotine Salt Based ENDS in Healthy Smokers | Biotech Hunter | Biotech Hunter